3/13
01:58 pm
ibrx
ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
Low
Report
ImmunityBio, Inc. (NASDAQ: IBRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
3/6
07:26 am
ibrx
ImmunityBio, Inc. (NASDAQ: IBRX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock.
Low
Report
ImmunityBio, Inc. (NASDAQ: IBRX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $8.00 price target on the stock.
3/6
06:05 am
ibrx
ImmunityBio initiated with a Buy at H.C. Wainwright
Low
Report
ImmunityBio initiated with a Buy at H.C. Wainwright
3/6
06:05 am
ibrx
ImmunityBio initiated with a Buy at H.C. Wainwright
Low
Report
ImmunityBio initiated with a Buy at H.C. Wainwright
1/10
01:21 pm
ibrx
Rating for IBRX
Low
Report
Rating for IBRX
1/10
09:03 am
ibrx
ImmunityBio, Inc. (NASDAQ: IBRX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $6.00 price target on the stock.
Medium
Report
ImmunityBio, Inc. (NASDAQ: IBRX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $6.00 price target on the stock.
1/10
06:49 am
ibrx
ImmunityBio initiated with a Buy at BTIG
Medium
Report
ImmunityBio initiated with a Buy at BTIG